- Home
- SBR vs CHEK Comparison
SBR vs CHEK Comparison
Compare SBR & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBR
- CHEK
- Stock Information
- Founded
- SBR 1982
- CHEK 2004
- Country
- SBR United States
- CHEK Israel
- Employees
- SBR N/A
- CHEK N/A
- Industry
- SBR Oil & Gas Production
- CHEK Medical Electronics
- Sector
- SBR Energy
- CHEK Health Care
- Exchange
- SBR Nasdaq
- CHEK Nasdaq
- Market Cap
- SBR N/A
- CHEK 4.5M
- IPO Year
- SBR N/A
- CHEK 2015
- Fundamental
- Price
- SBR $68.75
- CHEK $0.85
- Analyst Decision
- SBR
- CHEK
- Analyst Count
- SBR 0
- CHEK 0
- Target Price
- SBR N/A
- CHEK N/A
- AVG Volume (30 Days)
- SBR 28.6K
- CHEK 52.9K
- Earning Date
- SBR 01-01-0001
- CHEK 05-14-2025
- Dividend Yield
- SBR 7.81%
- CHEK N/A
- EPS Growth
- SBR N/A
- CHEK N/A
- EPS
- SBR 5.46
- CHEK N/A
- Revenue
- SBR $83,171,096.00
- CHEK N/A
- Revenue This Year
- SBR N/A
- CHEK N/A
- Revenue Next Year
- SBR N/A
- CHEK N/A
- P/E Ratio
- SBR $12.39
- CHEK N/A
- Revenue Growth
- SBR N/A
- CHEK N/A
- 52 Week Low
- SBR $58.60
- CHEK $0.56
- 52 Week High
- SBR $70.20
- CHEK $3.04
- Technical
- Relative Strength Index (RSI)
- SBR 58.30
- CHEK 51.99
- Support Level
- SBR $66.14
- CHEK $0.77
- Resistance Level
- SBR $68.30
- CHEK $0.93
- Average True Range (ATR)
- SBR 1.17
- CHEK 0.08
- MACD
- SBR 0.22
- CHEK 0.01
- Stochastic Oscillator
- SBR 84.54
- CHEK 67.02
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.